Advanced – Stage Hypopharyngeal Carcinoma Management: 25 years of Single Institutional Experience

Hypopharyngeal carcinoma is a rare malignancy which contributes to approximately 3 to 5% of head and neck carcinomas. Majority of these patients (70 to 85%) present with advanced-stage disease (stage III& IV). Regarding the treatment options, definitive surgery or laryngeal preservation using chemoradiotherapy are considered the standard of care, but there is a continuing debate on the outcomes due to conflicting data.
Source: International Journal of Radiation Oncology * Biology * Physics - Category: Radiology Authors: Source Type: research